Apo-Valgan

Χώρα: Νέα Ζηλανδία

Γλώσσα: Αγγλικά

Πηγή: Medsafe (Medicines Safety Authority)

Δραστική ουσία:

Valganciclovir hydrochloride 496.3mg equivalent to valganciclovir 450 mg

Διαθέσιμο από:

Apotex NZ Ltd

INN (Διεθνής Όνομα):

Valganciclovir hydrochloride 496.3 mg (= valganciclovir 450 mg)

Δοσολογία:

450 mg

Φαρμακοτεχνική μορφή:

Film coated tablet

Σύνθεση:

Active: Valganciclovir hydrochloride 496.3mg equivalent to valganciclovir 450 mg Excipient: Crospovidone Microcrystalline cellulose Opadry pink 80W540006 Purified water Stearic acid

Μονάδες σε πακέτο:

Blister pack, Al/Al, 60 tablets

Kατηγορία:

Prescription

Τρόπος διάθεσης:

Prescription

Κατασκευάζεται από:

Apotex Pharmachem India Pvt. Ltd.

Θεραπευτικές ενδείξεις:

Apo-Valgan is indicated for the treatment of cytomegalovirus (CMV) retinitis in acquired immunodeficiency syndrome (AIDS) patients.

Περίληψη προϊόντος:

Package - Contents - Shelf Life: Blister pack, Al/Al - 60 tablets - 24 months from date of manufacture stored at or below 25°C protect from light and moisture - Bottle, HDPE - 60 tablets - 24 months from date of manufacture stored at or below 25°C protect from light and moisture - Bottle, HDPE - 120 tablets - 24 months from date of manufacture stored at or below 25°C protect from light and moisture - Bottle, HDPE - 180 tablets - 24 months from date of manufacture stored at or below 25°C protect from light and moisture

Ημερομηνία της άδειας:

2012-07-05